|
1
|
Rodrigues AS, Dinis J, Gromicho M, Martins
C, Laires A and Rueff J: Genomics and cancer drug resistance. Curr
Pharm Biotechnol. 13:651–673. 2012. View Article : Google Scholar
|
|
2
|
Zhang X, Dong W, Zhou H, Li H, Wang N,
Miao X and Jia L: a-2, 8-Sialyltransferase is involved in the
development of multidrug resistance via PI3K/Akt pathway in human
chronic myeloid leukemia. IUBMB Life. 67:77–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalle AM, Sachchidanand S and Pallu R:
Bcr-Abl-independent mechanism of resistance to imatinib in K562
cells: Induction of cyclooxygenase-2 (COX-2) by histone
deacetylases (HDACs). Leuk Res. 34:1132–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma H, Cheng L, Hao K, Li Y, Song X, Zhou H
and Jia L: Reversal effect of ST6GAL 1 on multidrug resistance in
human leukemia by regulating the PI3K/Akt pathway and the
expression of P-gp and MRP1. PLoS One. 9:e851132014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng Z, Yang N, Liang W, Yan X, Li L and
Pan L: Effect of PTEN gene transfection on the reversal of
multidrug resistance in K562/ADM cells. Leuk Lymphoma.
53:1383–1389. 2012. View Article : Google Scholar
|
|
6
|
Dharmapuri G, Doneti R, Philip GH and
Kalle AM: Celecoxib sensitizes imatinib-resistant K562 cells to
imatinib by inhibiting MRP1–5, ABCA2 and ABCG2 transporters via Wnt
and Ras signaling pathways. Leuk Res. 39:696–701. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang Q and Yan S: Piperlongumine reverses
doxorubicin resistance through the PI3K/Akt signaling pathway in
K562/A02 human leukemia cells. Exp Ther Med. 9:1345–1350.
2015.PubMed/NCBI
|
|
8
|
Zhang Z, Xu K, Bi Y, Yu G, Wang S, Qi X
and Zhong H: Low intensity ultrasound promotes the sensitivity of
rat brain glioma to doxorubicin by downregulating the expressions
of P-glucoprotein and multidrug resistance protein 1 in vitro and
in vivo. PLoS One. 8:e706852013. View Article : Google Scholar
|
|
9
|
Barrett D, Brown VI, Grupp SA and Teachey
DT: Targeting the PI3K/AKT/mTOR signaling axis in children with
hematologic malignancies. Paediatr Drugs. 14:299–316.
2012.PubMed/NCBI
|
|
10
|
Sheng Z, Ma L, Sun JE, Zhu LJ and Green
MR: BCR-ABL suppresses autophagy through ATF5-mediated regulation
of mTOR transcription. Blood. 118:2840–2848. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Q, Wu Y, Fang S, Wang L, Qi H, Zhang Y,
Zhang J and Li W: BCR/ABL oncogene-induced PI3K signaling pathway
leads to chronic myeloid leukemia pathogenesis by impairing
immunomodulatory function of hemangioblasts. Cancer Gene Ther.
22:227–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Z, Yang L, Xia Y, Guo C and Kong L:
Icariin enhances cytotoxicity of doxorubicin in human
multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and
down-regulation of the PI3K/Akt pathway. Biol Pharm Bull.
38:277–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie X, Tang B, Zhou J, Gao Q and Zhang P:
Inhibition of the PI3K/Akt pathway increases the chemosensitivity
of gastric cancer to vincristine. Oncol Rep. 30:773–782.
2013.PubMed/NCBI
|
|
14
|
Tsou SH, Chen TM, Hsiao HT and Chen YH: A
critical dose of doxorubicin is required to alter the gene
expression profiles in MCF-7 cells acquiring multidrug resistance.
PLoS One. 10:e01167472015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng L, Luo S, Jin C, Ma H, Zhou H and
Jia L: FUT family mediates the multidrug resistance of human
hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell
Death Dis. 4:e9232013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee B, Jung K and Kim DH: Timosaponin
AIII, a saponin isolated from Anemarrhena asphodeloides,
ameliorates learning and memory deficits in mice. Pharmacol Biochem
Behav. 93:121–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim SM, Jeong JJ, Kang GD, Kim KA, Choi HS
and Kim DH: Timosaponin AIII and its metabolite sarsasapogenin
ameliorate colitis in mice by inhibiting NF-κB and MAPK activation
and restoring Th17/Treg cell balance. Int Immunopharmacol.
25:493–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee B, Trinh HT, Jung K, Han SJ and Kim
DH: Inhibitory effects of steroidal timosaponins isolated from the
rhizomes of Anemarrhena asphodeloides against passive cutaneous
anaphylaxis reaction and pruritus. Immunopharmacol Immunotoxicol.
32:357–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kimura M, Kimura I and Chem FJ: Combined
potentiating effect of byakko-ka-ninjin-to, its constituents,
rhizomes of Anemarrhena asphodeloitles, timosaponin A-III, and
calcium on pilocarpine-induced saliya secretion in
streptozocin-diabetic mice. Biol Pharm Bull. 19:926–931. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang YH, Sun ZL, Fan MS, Li ZX and Huang
CG: Anti-diabetic effects of TongGuanWan, a Chinese traditional
herbal formula, in C57BL/KsJ-db/db mice. Planta Med. 78:18–23.
2012. View Article : Google Scholar
|
|
21
|
Lok CN, Sy LK, Liu F and Che CM:
Activation of autophagy of aggregation-prone ubiquitinated proteins
by timosaponin A-III. J Biol Chem. 286:31684–31696. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kang YJ, Chung HJ, Nam JW, Park HJ, Seo
EK, Kim YS, Lee D and Lee SK: Cytotoxic and antineoplastic activity
of timosaponin A-III for human colon cancer cells. J Nat Prod.
74:701–706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang YZ, Feng B, Huang HZ, Kang LP, Cong
Y, Zhou WB, Zou P, Cong YW, Song XB and Ma BP: Glucosylation of
steroidal saponins by cyclodextrin glucanotransferase. Planta Med.
76:1724–1731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang HL, Chiang WL, Hsiao PC, Chien MH,
Chen HY, Weng WC, Hsieh MJ and Yang SF: Timosaponin AIII mediates
caspase activation and induces apoptosis through JNK1/2 pathway in
human promyelocytic leukemia cells. Tumour Biol. 36:3489–3497.
2015. View Article : Google Scholar
|
|
25
|
Wang S, Wang S, Wang C, Chen Y, Li J, Wang
X, Wang D, Li Z, Peng Z and Fan L: Upregulation of multidrug
resistance-associated protein 1 by Allyl isothiocyanate in human
bronchial epithelial cell: Involvement of c-Jun N-terminal kinase
signaling pathway. Oxid Med Cell. 2015:9037822015.
|
|
26
|
Wang L, Meng Q, Wang C, Liu Q, Peng J, Huo
X, Sun H, Ma X and Liu K: Dioscin restores the activity of the
anticancer agent adriamycin in multidrug-resistant human leukemia
K562/adriamycin cells by down-regulating MDR1 via a mechanism
involving NF-κB signaling inhibition. J Nat Prod. 76:909–914. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang H, Wang X, Li Y, Liao A, Fu B, Pan H,
Liu Z and Yang W: The proteasome inhibitor bortezomib reverses
P-glycoprotein-mediated leukemia multi-drug resistance through the
NF-B pathway. Pharmazie. 67:187–192. 2012.PubMed/NCBI
|
|
28
|
Xu X, Zhang Y, Li W, Miao H, Zhang H, Zhou
Y, Li Z, You Q, Zhao L and Guo Q: Wogonin reverses multi-drug
resistance of human myelogenous leukemia K562/A02 cells via
downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling
pathway. Biochem Pharmacol. 92:220–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sinclair A, Latif AL and Holyoake TL:
Targeting survival pathways in chronic myeloid leukaemia stem
cells. Br J Pharmacol. 169:1693–1707. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lage H: An overview of cancer multidrug
resistance: A still un-solved problem. Cell Mol Life Sci.
65:3145–3167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vasconcelos FC, Silva KL, Souza PS, Silva
LF, Moellmann-Coelho A, Klumb CE and Maia RC: Variation of MDR
proteins expression and activity levels according to clinical
status and evolution of CML patients. Cytometry B Clin Cytom.
80B:158–166. 2011. View Article : Google Scholar
|
|
32
|
Sy LK, Yan SC, Lok CN, Man RY and Che CM:
Timosaponin A-III induces autophagy preceding mitochondria-mediated
apoptosis in HeLa cancer cells. Cancer Res. 68:10229–10237. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang N, Feng Y, Zhu M, Siu FM, Ng KM and
Che CM: A novel mechanism of XIAP degradation induced by
timosaponin AIII in hepatocellular carcinoma. Biochim Biophys Acta.
1833:2890–2899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
King FW, Fong S, Griffin C, Shoemaker M,
Staub R, Zhang YL, Cohen I and Shtivelman E: Timosaponin AIII is
preferentially cytotoxic to tumor cells through inhibition of mTOR
and induction of ER stress. PLoS One. 4:e72832009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao F, Liu J, Dong WW, Wang W, Wang Y, Cai
D, Zheng Z and Sun K: Investigation of the mechanism involved in
the As2O3-regulated decrease in MDR1
expression in leukemia cells. Oncol Rep. 31:926–932. 2014.
|
|
36
|
Wang R, Shao F, Liu Z, Zhang J, Wang S,
Liu J, Liu H, Chen H, Liu K, Xia M, et al: The Hsp90 inhibitor
SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells
through suppression of Akt/NF-κB and disruption of
mitochondria-dependent pathways. Chem Biol Interact. 205:1–10.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu X, Wang L, Zhang B, Li J, Dou X and
Zhao RC: TGF-beta1-induced PI3K/Akt/NF-kappaB/MMP9 signalling
pathway is activated in Philadelphia chromosome-positive chronic
myeloid leukaemia hemangioblasts. J Biochem. 149:405–414. 2011.
View Article : Google Scholar : PubMed/NCBI
|
